These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11235863)

  • 21. Fluvoxamine-associated manic behavior: a case series.
    Dorevitch A; Frankel Y; Bar-Halperin A; Aronzon R; Zilberman L
    Ann Pharmacother; 1993 Dec; 27(12):1455-7. PubMed ID: 8305775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.
    Markowitz JS; DeVane CL; Liston HL; Montgomery SA
    Int Clin Psychopharmacol; 2000 Nov; 15(6):329-33. PubMed ID: 11110008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Discontinuation of antidepressant serotonergic antidepressant].
    Andersen CL; Videbech P
    Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvoxamine for symptomatic outpatients with COVID-19.
    Wu PE; Austin E; Leong D
    CMAJ; 2022 Feb; 194(7):E258. PubMed ID: 35045990
    [No Abstract]   [Full Text] [Related]  

  • 25. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
    Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
    Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood trichotillomania. Successful treatment with fluoxetine following an SSRI failure.
    Palmer CJ; Yates WR; Trotter L
    Psychosomatics; 1999; 40(6):526-8. PubMed ID: 10581985
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Violent acts associated with fluvoxamine treatment.
    Okada F; Okajima K
    J Psychiatry Neurosci; 2001 Sep; 26(4):339-40. PubMed ID: 11590975
    [No Abstract]   [Full Text] [Related]  

  • 29. Serotonin reuptake inhibitor withdrawal.
    Coupland NJ; Bell CJ; Potokar JP
    J Clin Psychopharmacol; 1996 Oct; 16(5):356-62. PubMed ID: 8889907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citalopram and fluvoxamine in Tourette's disorder.
    Bajo S; Battaglia M; Pegna C; Bellodi L
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):230-1. PubMed ID: 10087681
    [No Abstract]   [Full Text] [Related]  

  • 31. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluvoxamine and mandibular dystonia.
    Chong SA
    Can J Psychiatry; 1995 Sep; 40(7):430-1. PubMed ID: 8548729
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluvoxamine. A review of its safety profile in world-wide studies.
    Wagner W; Zaborny BA; Gray TE
    Int Clin Psychopharmacol; 1994; 9(4):223-7. PubMed ID: 7868844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seizure possibly associated with fluvoxamine.
    Kim KY; Craig JM; Hawley JM
    Ann Pharmacother; 2000 Nov; 34(11):1276-8. PubMed ID: 11098342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Discontinuation of SSRIs and SNRIs].
    Ruhe HG; Horikx A; van Avendonk MJP; Groeneweg BF; Mulder H; Woutersen-Koch H
    Ned Tijdschr Geneeskd; 2020 Feb; 164():. PubMed ID: 32186829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.
    van Geffen EC; Hugtenburg JG; Heerdink ER; van Hulten RP; Egberts AC
    Eur J Clin Pharmacol; 2005 Jun; 61(4):303-7. PubMed ID: 15906018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: two case reports.
    Chong SA; Tan CH; Lee HS
    J Clin Psychopharmacol; 1997 Feb; 17(1):68-9. PubMed ID: 9004072
    [No Abstract]   [Full Text] [Related]  

  • 38. SSRI-induced parkinsonism may be an early sign of future Parkinson's disease.
    Gönül AS; Aksu M
    J Clin Psychiatry; 1999 Jun; 60(6):410. PubMed ID: 10401924
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical management of antidepressant discontinuation.
    Rosenbaum JF; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():37-40. PubMed ID: 9219493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggravation of glaucoma with fluvoxamine.
    Jiménez-Jiménez FJ; Ortí-Pareja M; Zurdo JM
    Ann Pharmacother; 2001 Dec; 35(12):1565-6. PubMed ID: 11793621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.